J&J Vision announces availability of TECNIS Synergy IOL
Company introduces 'revolutionary' continuous-range-of-vision IOL
Priscilla Lynch
Published: Sunday, September 15, 2019
JOHNSON & Johnson Vision (JJV) invites ESCRS delegates to look at what the company describes as its “revolutionary” continuous-range-of-vision intraocular lens for patients with cataracts, which is now available in Europe, Australia and New Zealand.
“TECNIS Synergy™ IOL creates a new standard in presbyopia-correcting IOL technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions,” a company spokesperson said.
“With TECNIS Synergy IOL, we have created our most advanced IOL solution yet, which gives patients the clear, continuous range of vision they want, day and night,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision.
“As ophthalmic pioneers, we continue to challenge ourselves on a daily basis to create solutions to the ever-changing needs of patients. Today, we stay true to our legacy of innovation with the introduction of TECNIS Synergy IOL, which we believe will redefine the industry standard for IOL quality and performance.”
Visit the JJV booth to learn more – Pavilion 7, Floor 7.2 Booth #E112
Tags: intraocular lens
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.